nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—Lidocaine—EGFR—colon cancer	0.00827	0.767	CrCbGaD
Bupivacaine—Muscular weakness—Fluorouracil—colon cancer	0.00287	0.0029	CcSEcCtD
Bupivacaine—Sweating increased—Irinotecan—colon cancer	0.00286	0.00289	CcSEcCtD
Bupivacaine—Dysphagia—Fluorouracil—colon cancer	0.00281	0.00284	CcSEcCtD
Bupivacaine—Apnoea—Methotrexate—colon cancer	0.00275	0.00278	CcSEcCtD
Bupivacaine—Extravasation—Methotrexate—colon cancer	0.00267	0.0027	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Vincristine—colon cancer	0.00263	0.00266	CcSEcCtD
Bupivacaine—Musculoskeletal stiffness—Methotrexate—colon cancer	0.0026	0.00263	CcSEcCtD
Bupivacaine—Bone disorder—Methotrexate—colon cancer	0.00258	0.00261	CcSEcCtD
Bupivacaine—Skin discolouration—Methotrexate—colon cancer	0.00258	0.00261	CcSEcCtD
Bupivacaine—Sweating—Vincristine—colon cancer	0.00258	0.00261	CcSEcCtD
Bupivacaine—Vascular purpura—Capecitabine—colon cancer	0.00254	0.00257	CcSEcCtD
Bupivacaine—Lidocaine—ABCB1—colon cancer	0.00252	0.233	CrCbGaD
Bupivacaine—Sweating—Irinotecan—colon cancer	0.00251	0.00254	CcSEcCtD
Bupivacaine—Infestation NOS—Fluorouracil—colon cancer	0.00251	0.00253	CcSEcCtD
Bupivacaine—Infestation—Fluorouracil—colon cancer	0.00251	0.00253	CcSEcCtD
Bupivacaine—Dysarthria—Methotrexate—colon cancer	0.00247	0.00249	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Fluorouracil—colon cancer	0.00246	0.00248	CcSEcCtD
Bupivacaine—Urinary tract infection—Fluorouracil—colon cancer	0.00244	0.00246	CcSEcCtD
Bupivacaine—Hypoaesthesia—Vincristine—colon cancer	0.0024	0.00243	CcSEcCtD
Bupivacaine—Bradycardia—Irinotecan—colon cancer	0.00239	0.00242	CcSEcCtD
Bupivacaine—Respiratory failure—Methotrexate—colon cancer	0.00237	0.0024	CcSEcCtD
Bupivacaine—Purpura—Capecitabine—colon cancer	0.00236	0.00238	CcSEcCtD
Bupivacaine—Lethargy—Capecitabine—colon cancer	0.00232	0.00235	CcSEcCtD
Bupivacaine—Diplopia—Capecitabine—colon cancer	0.00227	0.0023	CcSEcCtD
Bupivacaine—Osteoarthritis—Capecitabine—colon cancer	0.00227	0.0023	CcSEcCtD
Bupivacaine—Depressed level of consciousness—Methotrexate—colon cancer	0.00225	0.00228	CcSEcCtD
Bupivacaine—Cardiac disorder—Vincristine—colon cancer	0.00224	0.00226	CcSEcCtD
Bupivacaine—Hypoaesthesia—Fluorouracil—colon cancer	0.00224	0.00226	CcSEcCtD
Bupivacaine—Flushing—Irinotecan—colon cancer	0.00218	0.0022	CcSEcCtD
Bupivacaine—Cardiac disorder—Irinotecan—colon cancer	0.00218	0.0022	CcSEcCtD
Bupivacaine—Cardiac arrest—Capecitabine—colon cancer	0.00216	0.00219	CcSEcCtD
Bupivacaine—Urinary retention—Capecitabine—colon cancer	0.00216	0.00219	CcSEcCtD
Bupivacaine—Blood creatinine increased—Capecitabine—colon cancer	0.00213	0.00215	CcSEcCtD
Bupivacaine—Mental disorder—Vincristine—colon cancer	0.00211	0.00214	CcSEcCtD
Bupivacaine—Chills—Irinotecan—colon cancer	0.00211	0.00213	CcSEcCtD
Bupivacaine—Arrhythmia—Irinotecan—colon cancer	0.0021	0.00212	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Capecitabine—colon cancer	0.00208	0.0021	CcSEcCtD
Bupivacaine—Pulmonary oedema—Methotrexate—colon cancer	0.00208	0.0021	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.00205	0.00207	CcSEcCtD
Bupivacaine—Back pain—Vincristine—colon cancer	0.00203	0.00205	CcSEcCtD
Bupivacaine—Flatulence—Irinotecan—colon cancer	0.00202	0.00204	CcSEcCtD
Bupivacaine—Arrhythmia—Fluorouracil—colon cancer	0.00201	0.00203	CcSEcCtD
Bupivacaine—Muscular weakness—Capecitabine—colon cancer	0.00201	0.00203	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00201	0.00203	CcSEcCtD
Bupivacaine—Back pain—Irinotecan—colon cancer	0.00198	0.002	CcSEcCtD
Bupivacaine—Abdominal distension—Capecitabine—colon cancer	0.00198	0.002	CcSEcCtD
Bupivacaine—Muscle spasms—Irinotecan—colon cancer	0.00197	0.00199	CcSEcCtD
Bupivacaine—Dysphagia—Capecitabine—colon cancer	0.00196	0.00199	CcSEcCtD
Bupivacaine—Erythema—Fluorouracil—colon cancer	0.00196	0.00198	CcSEcCtD
Bupivacaine—Anaemia—Vincristine—colon cancer	0.00194	0.00196	CcSEcCtD
Bupivacaine—Bronchospasm—Capecitabine—colon cancer	0.00193	0.00195	CcSEcCtD
Bupivacaine—Agitation—Vincristine—colon cancer	0.00193	0.00195	CcSEcCtD
Bupivacaine—Sweating increased—Capecitabine—colon cancer	0.00191	0.00193	CcSEcCtD
Bupivacaine—Anaemia—Irinotecan—colon cancer	0.00189	0.00191	CcSEcCtD
Bupivacaine—Vision blurred—Fluorouracil—colon cancer	0.00185	0.00187	CcSEcCtD
Bupivacaine—Syncope—Irinotecan—colon cancer	0.00183	0.00185	CcSEcCtD
Bupivacaine—Convulsion—Vincristine—colon cancer	0.00182	0.00184	CcSEcCtD
Bupivacaine—Hypertension—Vincristine—colon cancer	0.00181	0.00183	CcSEcCtD
Bupivacaine—Anaemia—Fluorouracil—colon cancer	0.00181	0.00183	CcSEcCtD
Bupivacaine—Loss of consciousness—Irinotecan—colon cancer	0.0018	0.00182	CcSEcCtD
Bupivacaine—Cough—Irinotecan—colon cancer	0.00179	0.0018	CcSEcCtD
Bupivacaine—Hypertension—Irinotecan—colon cancer	0.00177	0.00179	CcSEcCtD
Bupivacaine—Infestation—Capecitabine—colon cancer	0.00175	0.00177	CcSEcCtD
Bupivacaine—Infestation NOS—Capecitabine—colon cancer	0.00175	0.00177	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00175	0.00177	CcSEcCtD
Bupivacaine—Lethargy—Methotrexate—colon cancer	0.00173	0.00175	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Capecitabine—colon cancer	0.00172	0.00174	CcSEcCtD
Bupivacaine—Anaphylactic shock—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Bupivacaine—Oedema—Vincristine—colon cancer	0.00171	0.00173	CcSEcCtD
Bupivacaine—Infection—Vincristine—colon cancer	0.0017	0.00172	CcSEcCtD
Bupivacaine—Urinary tract infection—Capecitabine—colon cancer	0.0017	0.00172	CcSEcCtD
Bupivacaine—Convulsion—Fluorouracil—colon cancer	0.0017	0.00172	CcSEcCtD
Bupivacaine—Osteoarthritis—Methotrexate—colon cancer	0.00169	0.00171	CcSEcCtD
Bupivacaine—Confusional state—Irinotecan—colon cancer	0.00168	0.0017	CcSEcCtD
Bupivacaine—Nervous system disorder—Vincristine—colon cancer	0.00168	0.0017	CcSEcCtD
Bupivacaine—Haematuria—Capecitabine—colon cancer	0.00167	0.00169	CcSEcCtD
Bupivacaine—Oedema—Irinotecan—colon cancer	0.00167	0.00169	CcSEcCtD
Bupivacaine—Anaphylactic shock—Irinotecan—colon cancer	0.00167	0.00169	CcSEcCtD
Bupivacaine—Infection—Irinotecan—colon cancer	0.00166	0.00168	CcSEcCtD
Bupivacaine—Hyperhidrosis—Vincristine—colon cancer	0.00166	0.00168	CcSEcCtD
Bupivacaine—Shock—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Bupivacaine—Nervous system disorder—Irinotecan—colon cancer	0.00164	0.00166	CcSEcCtD
Bupivacaine—Hyperhidrosis—Irinotecan—colon cancer	0.00161	0.00163	CcSEcCtD
Bupivacaine—Confusional state—Fluorouracil—colon cancer	0.00161	0.00163	CcSEcCtD
Bupivacaine—Hypotension—Vincristine—colon cancer	0.0016	0.00162	CcSEcCtD
Bupivacaine—Bradycardia—Capecitabine—colon cancer	0.0016	0.00162	CcSEcCtD
Bupivacaine—Anaphylactic shock—Fluorouracil—colon cancer	0.0016	0.00162	CcSEcCtD
Bupivacaine—Oedema—Fluorouracil—colon cancer	0.0016	0.00162	CcSEcCtD
Bupivacaine—Infection—Fluorouracil—colon cancer	0.00159	0.00161	CcSEcCtD
Bupivacaine—Nervous system disorder—Fluorouracil—colon cancer	0.00157	0.00159	CcSEcCtD
Bupivacaine—Hypoaesthesia—Capecitabine—colon cancer	0.00156	0.00158	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00156	0.00158	CcSEcCtD
Bupivacaine—Tachycardia—Fluorouracil—colon cancer	0.00156	0.00158	CcSEcCtD
Bupivacaine—Hypotension—Irinotecan—colon cancer	0.00156	0.00158	CcSEcCtD
Bupivacaine—Insomnia—Vincristine—colon cancer	0.00155	0.00157	CcSEcCtD
Bupivacaine—Oedema peripheral—Capecitabine—colon cancer	0.00155	0.00157	CcSEcCtD
Bupivacaine—Paraesthesia—Vincristine—colon cancer	0.00154	0.00156	CcSEcCtD
Bupivacaine—Insomnia—Irinotecan—colon cancer	0.00151	0.00153	CcSEcCtD
Bupivacaine—Paraesthesia—Irinotecan—colon cancer	0.0015	0.00152	CcSEcCtD
Bupivacaine—Hypotension—Fluorouracil—colon cancer	0.00149	0.00151	CcSEcCtD
Bupivacaine—Decreased appetite—Vincristine—colon cancer	0.00149	0.00151	CcSEcCtD
Bupivacaine—Dyspnoea—Irinotecan—colon cancer	0.00149	0.0015	CcSEcCtD
Bupivacaine—Somnolence—Irinotecan—colon cancer	0.00148	0.0015	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Vincristine—colon cancer	0.00148	0.0015	CcSEcCtD
Bupivacaine—Dyspepsia—Irinotecan—colon cancer	0.00147	0.00149	CcSEcCtD
Bupivacaine—Tinnitus—Capecitabine—colon cancer	0.00147	0.00148	CcSEcCtD
Bupivacaine—Constipation—Vincristine—colon cancer	0.00147	0.00148	CcSEcCtD
Bupivacaine—Pain—Vincristine—colon cancer	0.00147	0.00148	CcSEcCtD
Bupivacaine—Flushing—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Bupivacaine—Cardiac disorder—Capecitabine—colon cancer	0.00146	0.00148	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00146	0.00147	CcSEcCtD
Bupivacaine—Decreased appetite—Irinotecan—colon cancer	0.00145	0.00147	CcSEcCtD
Bupivacaine—Insomnia—Fluorouracil—colon cancer	0.00145	0.00146	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00144	0.00146	CcSEcCtD
Bupivacaine—Paraesthesia—Fluorouracil—colon cancer	0.00144	0.00145	CcSEcCtD
Bupivacaine—Constipation—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Bupivacaine—Pain—Irinotecan—colon cancer	0.00143	0.00144	CcSEcCtD
Bupivacaine—Dyspnoea—Fluorouracil—colon cancer	0.00143	0.00144	CcSEcCtD
Bupivacaine—Somnolence—Fluorouracil—colon cancer	0.00142	0.00144	CcSEcCtD
Bupivacaine—Chills—Capecitabine—colon cancer	0.00141	0.00143	CcSEcCtD
Bupivacaine—Dyspepsia—Fluorouracil—colon cancer	0.00141	0.00142	CcSEcCtD
Bupivacaine—Arrhythmia—Capecitabine—colon cancer	0.00141	0.00142	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Vincristine—colon cancer	0.0014	0.00142	CcSEcCtD
Bupivacaine—Decreased appetite—Fluorouracil—colon cancer	0.00139	0.00141	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00138	0.0014	CcSEcCtD
Bupivacaine—Mental disorder—Capecitabine—colon cancer	0.00138	0.00139	CcSEcCtD
Bupivacaine—Feeling abnormal—Irinotecan—colon cancer	0.00138	0.00139	CcSEcCtD
Bupivacaine—Erythema—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Bupivacaine—Malnutrition—Capecitabine—colon cancer	0.00137	0.00138	CcSEcCtD
Bupivacaine—Pain—Fluorouracil—colon cancer	0.00137	0.00138	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Irinotecan—colon cancer	0.00137	0.00138	CcSEcCtD
Bupivacaine—Abdominal pain—Vincristine—colon cancer	0.00136	0.00137	CcSEcCtD
Bupivacaine—Body temperature increased—Vincristine—colon cancer	0.00136	0.00137	CcSEcCtD
Bupivacaine—Flatulence—Capecitabine—colon cancer	0.00135	0.00136	CcSEcCtD
Bupivacaine—Back pain—Capecitabine—colon cancer	0.00132	0.00134	CcSEcCtD
Bupivacaine—Body temperature increased—Irinotecan—colon cancer	0.00132	0.00133	CcSEcCtD
Bupivacaine—Abdominal pain—Irinotecan—colon cancer	0.00132	0.00133	CcSEcCtD
Bupivacaine—Feeling abnormal—Fluorouracil—colon cancer	0.00132	0.00133	CcSEcCtD
Bupivacaine—Muscle spasms—Capecitabine—colon cancer	0.00132	0.00133	CcSEcCtD
Bupivacaine—Infestation—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Bupivacaine—Drowsiness—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Bupivacaine—Infestation NOS—Methotrexate—colon cancer	0.0013	0.00132	CcSEcCtD
Bupivacaine—Vision blurred—Capecitabine—colon cancer	0.00129	0.0013	CcSEcCtD
Bupivacaine—Tremor—Capecitabine—colon cancer	0.00128	0.0013	CcSEcCtD
Bupivacaine—Urticaria—Fluorouracil—colon cancer	0.00127	0.00128	CcSEcCtD
Bupivacaine—Anaemia—Capecitabine—colon cancer	0.00127	0.00128	CcSEcCtD
Bupivacaine—Body temperature increased—Fluorouracil—colon cancer	0.00126	0.00128	CcSEcCtD
Bupivacaine—Hypersensitivity—Vincristine—colon cancer	0.00126	0.00128	CcSEcCtD
Bupivacaine—Sweating—Methotrexate—colon cancer	0.00125	0.00126	CcSEcCtD
Bupivacaine—Haematuria—Methotrexate—colon cancer	0.00124	0.00126	CcSEcCtD
Bupivacaine—Hypersensitivity—Irinotecan—colon cancer	0.00123	0.00124	CcSEcCtD
Bupivacaine—Asthenia—Vincristine—colon cancer	0.00123	0.00124	CcSEcCtD
Bupivacaine—Syncope—Capecitabine—colon cancer	0.00123	0.00124	CcSEcCtD
Bupivacaine—Palpitations—Capecitabine—colon cancer	0.00121	0.00122	CcSEcCtD
Bupivacaine—Loss of consciousness—Capecitabine—colon cancer	0.0012	0.00122	CcSEcCtD
Bupivacaine—Asthenia—Irinotecan—colon cancer	0.0012	0.00121	CcSEcCtD
Bupivacaine—Cough—Capecitabine—colon cancer	0.00119	0.00121	CcSEcCtD
Bupivacaine—Hypertension—Capecitabine—colon cancer	0.00118	0.00119	CcSEcCtD
Bupivacaine—Hypersensitivity—Fluorouracil—colon cancer	0.00118	0.00119	CcSEcCtD
Bupivacaine—Diarrhoea—Vincristine—colon cancer	0.00117	0.00119	CcSEcCtD
Bupivacaine—Arthralgia—Capecitabine—colon cancer	0.00117	0.00118	CcSEcCtD
Bupivacaine—Anxiety—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00116	0.00117	CcSEcCtD
Bupivacaine—Diarrhoea—Irinotecan—colon cancer	0.00114	0.00115	CcSEcCtD
Bupivacaine—Dizziness—Vincristine—colon cancer	0.00113	0.00115	CcSEcCtD
Bupivacaine—Pruritus—Fluorouracil—colon cancer	0.00113	0.00114	CcSEcCtD
Bupivacaine—Confusional state—Capecitabine—colon cancer	0.00113	0.00114	CcSEcCtD
Bupivacaine—Oedema—Capecitabine—colon cancer	0.00112	0.00113	CcSEcCtD
Bupivacaine—Infection—Capecitabine—colon cancer	0.00111	0.00112	CcSEcCtD
Bupivacaine—Dizziness—Irinotecan—colon cancer	0.0011	0.00112	CcSEcCtD
Bupivacaine—Shock—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Bupivacaine—Nervous system disorder—Capecitabine—colon cancer	0.0011	0.00111	CcSEcCtD
Bupivacaine—Diarrhoea—Fluorouracil—colon cancer	0.00109	0.00111	CcSEcCtD
Bupivacaine—Tinnitus—Methotrexate—colon cancer	0.00109	0.0011	CcSEcCtD
Bupivacaine—Tachycardia—Capecitabine—colon cancer	0.00109	0.0011	CcSEcCtD
Bupivacaine—Vomiting—Vincristine—colon cancer	0.00109	0.0011	CcSEcCtD
Bupivacaine—Cardiac disorder—Methotrexate—colon cancer	0.00109	0.0011	CcSEcCtD
Bupivacaine—Skin disorder—Capecitabine—colon cancer	0.00109	0.0011	CcSEcCtD
Bupivacaine—Hyperhidrosis—Capecitabine—colon cancer	0.00108	0.00109	CcSEcCtD
Bupivacaine—Headache—Vincristine—colon cancer	0.00107	0.00109	CcSEcCtD
Bupivacaine—Vomiting—Irinotecan—colon cancer	0.00106	0.00107	CcSEcCtD
Bupivacaine—Dizziness—Fluorouracil—colon cancer	0.00106	0.00107	CcSEcCtD
Bupivacaine—Chills—Methotrexate—colon cancer	0.00105	0.00106	CcSEcCtD
Bupivacaine—Headache—Irinotecan—colon cancer	0.00105	0.00106	CcSEcCtD
Bupivacaine—Hypotension—Capecitabine—colon cancer	0.00104	0.00106	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—colon cancer	0.00103	0.00104	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Bupivacaine—Malnutrition—Methotrexate—colon cancer	0.00102	0.00103	CcSEcCtD
Bupivacaine—Nausea—Vincristine—colon cancer	0.00102	0.00103	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00102	0.00103	CcSEcCtD
Bupivacaine—Vomiting—Fluorouracil—colon cancer	0.00102	0.00103	CcSEcCtD
Bupivacaine—Insomnia—Capecitabine—colon cancer	0.00101	0.00102	CcSEcCtD
Bupivacaine—Paraesthesia—Capecitabine—colon cancer	0.001	0.00101	CcSEcCtD
Bupivacaine—Headache—Fluorouracil—colon cancer	0.001	0.00101	CcSEcCtD
Bupivacaine—Dyspnoea—Capecitabine—colon cancer	0.000996	0.00101	CcSEcCtD
Bupivacaine—Nausea—Irinotecan—colon cancer	0.000992	0.001	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—colon cancer	0.000986	0.000997	CcSEcCtD
Bupivacaine—Dyspepsia—Capecitabine—colon cancer	0.000984	0.000994	CcSEcCtD
Bupivacaine—Decreased appetite—Capecitabine—colon cancer	0.000971	0.000982	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000965	0.000975	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—colon cancer	0.000961	0.000971	CcSEcCtD
Bupivacaine—Pain—Capecitabine—colon cancer	0.000956	0.000966	CcSEcCtD
Bupivacaine—Constipation—Capecitabine—colon cancer	0.000956	0.000966	CcSEcCtD
Bupivacaine—Nausea—Fluorouracil—colon cancer	0.00095	0.00096	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—colon cancer	0.000942	0.000952	CcSEcCtD
Bupivacaine—Feeling abnormal—Capecitabine—colon cancer	0.000921	0.000931	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Capecitabine—colon cancer	0.000914	0.000924	CcSEcCtD
Bupivacaine—Cough—Methotrexate—colon cancer	0.000889	0.000899	CcSEcCtD
Bupivacaine—Urticaria—Capecitabine—colon cancer	0.000888	0.000897	CcSEcCtD
Bupivacaine—Abdominal pain—Capecitabine—colon cancer	0.000883	0.000893	CcSEcCtD
Bupivacaine—Body temperature increased—Capecitabine—colon cancer	0.000883	0.000893	CcSEcCtD
Bupivacaine—Convulsion—Methotrexate—colon cancer	0.000883	0.000893	CcSEcCtD
Bupivacaine—Arthralgia—Methotrexate—colon cancer	0.000868	0.000877	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000862	0.000871	CcSEcCtD
Bupivacaine—Confusional state—Methotrexate—colon cancer	0.000839	0.000848	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—colon cancer	0.000832	0.000841	CcSEcCtD
Bupivacaine—Infection—Methotrexate—colon cancer	0.000826	0.000835	CcSEcCtD
Bupivacaine—Hypersensitivity—Capecitabine—colon cancer	0.000823	0.000832	CcSEcCtD
Bupivacaine—Nervous system disorder—Methotrexate—colon cancer	0.000816	0.000825	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—colon cancer	0.000808	0.000817	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—colon cancer	0.000804	0.000813	CcSEcCtD
Bupivacaine—Asthenia—Capecitabine—colon cancer	0.000802	0.00081	CcSEcCtD
Bupivacaine—Pruritus—Capecitabine—colon cancer	0.000791	0.000799	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—colon cancer	0.000777	0.000786	CcSEcCtD
Bupivacaine—Diarrhoea—Capecitabine—colon cancer	0.000765	0.000773	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000758	0.000766	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—colon cancer	0.000752	0.000761	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—colon cancer	0.000747	0.000755	CcSEcCtD
Bupivacaine—Dyspnoea—Methotrexate—colon cancer	0.000742	0.00075	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—colon cancer	0.00074	0.000748	CcSEcCtD
Bupivacaine—Dizziness—Capecitabine—colon cancer	0.000739	0.000747	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—colon cancer	0.000732	0.00074	CcSEcCtD
Bupivacaine—Decreased appetite—Methotrexate—colon cancer	0.000723	0.000731	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000718	0.000726	CcSEcCtD
Bupivacaine—Pain—Methotrexate—colon cancer	0.000711	0.000719	CcSEcCtD
Bupivacaine—Vomiting—Capecitabine—colon cancer	0.00071	0.000718	CcSEcCtD
Bupivacaine—Headache—Capecitabine—colon cancer	0.0007	0.000708	CcSEcCtD
Bupivacaine—Feeling abnormal—Methotrexate—colon cancer	0.000685	0.000693	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methotrexate—colon cancer	0.00068	0.000688	CcSEcCtD
Bupivacaine—Nausea—Capecitabine—colon cancer	0.000664	0.000671	CcSEcCtD
Bupivacaine—Urticaria—Methotrexate—colon cancer	0.000661	0.000668	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—colon cancer	0.000658	0.000665	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—colon cancer	0.000658	0.000665	CcSEcCtD
Bupivacaine—Hypersensitivity—Methotrexate—colon cancer	0.000613	0.00062	CcSEcCtD
Bupivacaine—Asthenia—Methotrexate—colon cancer	0.000597	0.000603	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—colon cancer	0.000589	0.000595	CcSEcCtD
Bupivacaine—Diarrhoea—Methotrexate—colon cancer	0.000569	0.000575	CcSEcCtD
Bupivacaine—Dizziness—Methotrexate—colon cancer	0.00055	0.000556	CcSEcCtD
Bupivacaine—Vomiting—Methotrexate—colon cancer	0.000529	0.000535	CcSEcCtD
Bupivacaine—Headache—Methotrexate—colon cancer	0.000521	0.000527	CcSEcCtD
Bupivacaine—Nausea—Methotrexate—colon cancer	0.000494	0.000499	CcSEcCtD
